Prasad
Favicon Fierce Biotech

CBER Director Vinay Prasad to depart FDA—again

Prasad has drawn increased criticism throughout his tenure, especially from the rare disease community.
Darren Incorvaia Mar 6, 2026 5:30pm
data deal handshake

Novo and Hims & Hers team up to sell branded GLP-1s, ending feud

Mar 9, 2026 11:55am
Uniting for patients Helping more Americans navigate access and afford their healthcare

Uniting for patients: Navigating, accessing, and affording care

Brought to you by Patient Advocate Foundation
Bristol Myers Squibb

FDA expands label for BMS' Sotyktu to treat psoriatic arthritis

Mar 9, 2026 11:16am
NBC Saturday Night Live Otezla parody ad

‘SNL’ pokes fun at mysteries of Amgen’s Otezla for psoriasis

Mar 9, 2026 11:05am
Zynyz

Novo's Indiana plant claims another victim in Incyte's PD-1

Mar 9, 2026 10:45am
More News

Safety signals prompt Ipsen to withdraw cancer med Tazverik

Mar 9, 2026 10:07am

Lonza shakes off capsule business in $3B deal with Lone Star

Mar 6, 2026 4:00pm

7 Democrats press pharmas for details on Trump MFN agreements

Mar 6, 2026 2:52pm

Sanofi sells generics unit to Brazil's EMS

Mar 6, 2026 2:00pm